• DMG-PEG2000-NH2: Optimizing Lipid Nanoparticles for Drug Del

  2026-05-02

  DMG-PEG2000-NH2 stands at the forefront of lipid nanoparticle and liposomal drug delivery, offering exceptional biocompatibility and conjugation reliability for siRNA and peptide encapsulation. This guide translates current research and best practices into actionable workflows, data-driven troubleshooting, and advanced use-cases to maximize your results with this NH2-PEG derivative.

• Liproxstatin-1: Reliable Ferroptosis Inhibitor for Cell Assa

  2026-05-01

  This article addresses core challenges in cell viability and ferroptosis research, demonstrating how Liproxstatin-1 (SKU B4987) delivers reproducible inhibition of iron-dependent cell death. Integrating literature evidence and real-world lab scenarios, it provides best-practice guidance for protocol optimization, data interpretation, and reliable product selection.

• MG-262 (Z-Leu-Leu-Leu-B(OH)2): Precision Tools for Muscle Pr

  2026-05-01

  Explore how MG-262 (Z-Leu-Leu-Leu-B(OH)2) advances skeletal muscle proteostasis research and proteasome inhibition assays. This in-depth guide uniquely links proteasome activity, chaperone-mediated autophagy, and cutting-edge assay design.

• Fluconazole: A Benchmark Fungal Cytochrome P450 Inhibitor

  2026-04-30

  Fluconazole is a triazole-based antifungal and a key fungal cytochrome P450 enzyme 14α-demethylase inhibitor. It is widely used for ergosterol biosynthesis inhibition and antifungal susceptibility testing in research. This article details its mechanism, benchmarks, and critical application boundaries.

• Clathrin-Mediated Endocytosis in Grass Carp Reovirus Entry:

  2026-04-30

  Wang et al. (2018) establish that clathrin-mediated endocytosis, requiring both dynamin and endosomal acidification, is essential for the cellular entry of type III grass carp reovirus (GCRV104). The study also demonstrates that the protein kinase C inhibitor Rottlerin significantly impedes viral entry and replication, providing new mechanistic understanding and experimental tools for dissecting virus-host interactions.

• Ibrexafungerp Efficacy in Fluconazole-Resistant Candida auri

  2026-04-29

  Wiederhold et al. demonstrate that ibrexafungerp, a first-in-class triterpenoid, displays potent in vitro and in vivo activity against fluconazole-resistant Candida auris. The study provides crucial comparative evidence on antifungal efficacy and highlights ongoing challenges in treating multidrug-resistant invasive candidiasis.

• Biomimetic Microparticles Disrupt Tumor pH for Chemo-Immunot

  2026-04-29

  This study presents a biomimetic microparticle system that simultaneously disrupts intracellular and extracellular pH homeostasis in tumor cells by co-delivering syrosingopine and a doxorubicin prodrug. The approach enhances chemotherapeutic and immunotherapeutic efficacy, addressing metabolic adaptations and immune suppression in the tumor microenvironment.

• Ferrostatin-1 (Fer-1): Precision Tools for Ferroptosis in De

  2026-04-28

  Explore how Ferrostatin-1 (Fer-1) empowers advanced ferroptosis assays in developmental and disease models. This article uniquely bridges mechanistic insights with practical protocol guidance for oxidative lipid damage inhibition research.

• Omicron KP.3 RBD mRNA Vaccine: Broad Neutralization in Mice

  2026-04-28

  The referenced study introduces an mRNA vaccine encoding the Omicron KP.3 RBD, demonstrating broad neutralization against multiple SARS-CoV-2 Omicron subvariants and robust protection in a mouse model. This work highlights the value of nucleoside-modified mRNA and supports ongoing efforts to optimize mRNA vaccine platforms for evolving viral threats.

• Griseofulvin's Role in Aneugenicity Assays: Mechanisms and R

  2026-04-27

  Explore how Griseofulvin, a microtubule associated inhibitor, enables precision in aneugenicity assays and antifungal drug research. This article uniquely analyzes assay decision-making and mechanistic insights beyond standard antifungal perspectives.

• Mifepristone (RU486): Data-Driven Solutions for Cell Assays

  2026-04-27

  This article addresses real-world laboratory challenges in cell viability, proliferation, and hormone signaling assays, focusing on the validated performance of Mifepristone (RU486) (SKU B1511). With evidence-based answers and scenario-driven guidance, researchers can optimize experimental rigor and reproducibility using APExBIO’s high-purity reagent.

• PP2A-Mediated Autophagy Drives Candida albicans Biofilm Resi

  2026-04-26

  This study uncovers how protein phosphatase 2A (PP2A) modulates biofilm formation and drug resistance in Candida albicans by inducing autophagy via ATG protein phosphorylation. The findings highlight a critical regulatory node influencing antifungal susceptibility and suggest new avenues for targeting biofilm-associated resistance.

• Fluconazole as a Probe for Autophagy-Driven Antifungal Resis

  2026-04-25

  Explore how Fluconazole, a fungal cytochrome P450 enzyme 14α-demethylase inhibitor, empowers advanced research into autophagy-mediated drug resistance in Candida albicans. This article uniquely bridges mechanistic insights with practical protocol guidance for antifungal susceptibility testing.

• Mechanistic Blueprint of ZAK Activation at Collided Ribosome

  2026-04-24

  This study employs cryo-EM and biochemical analyses to elucidate the structural and mechanistic determinants of ZAK kinase activation during ribosome collisions, a key trigger of the ribotoxic stress response. The findings clarify how RACK1 scaffolding and SAM domain dimerization enable collision-specific ZAK activation, with implications for understanding cellular stress signaling and kinase regulation.

• Ertugliflozin Modulates Insulin Signaling and Tau in Alzheim

  2026-04-24

  This study demonstrates that Ertugliflozin (PF-04971729), a selective SGLT2 inhibitor, can attenuate cognitive deficits and mitigate tau hyperphosphorylation in a rat model of Alzheimer’s disease induced by brain insulin resistance. The findings suggest a novel neuroprotective role for SGLT2 inhibition, linking diabetes mellitus research with neurodegenerative disease mechanisms.

16553 records 1/1104 page Next 12345 下5页 Last page